Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

Launched by THE UNIVERSITY OF QUEENSLAND · Jan 28, 2025

Keywords

ClinConnect Summary

The PIVO Trial is a study aimed at improving the way blood samples are taken to check for infections. Blood cultures are important tests that help doctors find out if a patient has an infection in their bloodstream. Sometimes, these tests can be affected by germs getting into the sample or by not having enough blood collected, which makes the test results unreliable. This trial will use a special device called the PIVO Pro, which allows blood to be drawn through an existing catheter (a small tube placed in the vein), instead of using a needle. The goal is to see if this method leads to fewer problems with contamination compared to the traditional needle method.

To participate in the trial, you need to be 18 years or older and have a blood culture test ordered because your doctor suspects you might have an infection in your bloodstream. You should also be receiving a specific type of catheter for the blood draw. If you join the study, you won’t need to do anything extra; researchers will collect information about your blood sample from your medical records. Half of the participants will have their blood drawn using the PIVO Pro device, while the other half will have it done the usual way with a needle. This trial is not yet recruiting participants, but it aims to make blood testing easier and less uncomfortable for patients in emergency departments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Blood culture requested due to suspected bloodstream infection
• • Patients receiving a 22 gauge short peripheral intravenous catheter (or larger)
• Exclusion Criteria:
• • Patients who have already commenced intravenous antimicrobial medications in the emergency department